Fortification of the food supply with folic acid to prevent neural tube defects is not yet warranted

Journal of Nutrition

Volumn 126, Issue 3, 1996, Pages

  Gaull, Gerald E ^a,b   Testa, Cynthia A ^a   Thomas, Paul R ^a   Weinreich, Debra Appel ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b Policy Associate National Center for Food and Agricultural Policy   (United States)

Author keywords

folic acid; fortification; neural tube defects; public policy

Indexed keywords

ARTICLE; FOLIC ACID DEFICIENCY; FOOD COMPOSITION; NEURAL TUBE DEFECT;

ADULT; ANEMIA, PERNICIOUS; ARTERIOSCLEROSIS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FEMALE; FOLIC ACID; FOOD, FORTIFIED; HUMANS; INCIDENCE; INFANT, NEWBORN; NEURAL TUBE DEFECTS; PREGNANCY; RISK FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0029878495     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Adams, M. J., Khoury, M. J., Stevenson, R., Haddow, J., Knight, G. & Allen, R. H. (1993) Midtrimester serum methylmalonic acid as a risk marker for neural tube defects. Teratology 47: 384 (abs.).
2. Boushey, C. J., Beresford, S. A. A., Omenn, G. S. & Motulsky, A. G. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. J. Am. Med. Assoc. 274: 1049-1057.
3. Bower, C., Stanley, F. J., Croft, M., DeKlerk, N. H., Davis, R. E. & Nicol, D. J. (1993) Absorption of pteroylpolyglutamates in mothers of infants with neural tube defects. Br. J. Nutr. 69: 827-834.
4. Carmel, R. & Johnson, C. S. (1978) Racial patterns in pernicious anemia. N. Engl. J. Med. 298: 647-650.
5. CDC (Centers for Disease Control) (1992a) Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 41(RR-14): 1-7.
6. CDC (Centers for Disease Control) (1992b) Spina bifida incidence at birth - United States, 1983-1990. MMWR 41: 497-500.
7. Coelho, C. N. D. & Klein, N. W. (1990) Methionine and neural tube closure in cultured rat embryos: morphological and biochemical analyses. Teratology 42: 437-451.
8. Coelho, C. N. D., Weber, J. A., Klein, N. W., Daniels, W. G. & Hoagland, T. A. (1989) Whole rat embryos require methionine for neural tube closure when cultured on cow serum. J. Nutr. 119: 1716-1725.
9. Crane, N. T., Wilson, D. B., Cook, A., Lewis, C. J., Yetley, E. A. & Rader, J. I. (1995) Evaluating food fortification options: general principles revisited with folic acid. Am. J. Public Health 85: 660-666.
10. Czeizel, A. E. & Dudás, I. (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327: 1832-1835.
11. Economides, D. L., Ferguson, J., Mackenzie, I. Z., Darley, J., Ware, I. I. & Holmes-Siedle, M. (1992) Folate and vitamin B-12 concentrations in maternal and fetal blood, and amniotic fluid in second trimester pregnancies complicated by neural tube defects. Br. J. Obstet. Gynaecol. 99: 23-25.
12. Elwood, M., Elwood, H. & Little, J. (1992) Diet. In: Epidemiology and Control of Neural Tube Defects (Elwood, M., Little, J. & Elwood, H., eds.), pp. 521-603. Oxford University Press, New York, NY.
13. Gaull, G. E., Rassin, D. K. & Sturman, J. A. (1968) Pyridoxine-dependency in homocystinuria. Lancet 2: 1302 (lett.).
14. Hall, M. H. (1972) Folic acid deficiency and congenital malformation. J. Obstet. Gynaecol. Br. Commonw. 79: 159-161.
15. Hoffbrand, A. V., Newcombe, B. F. A. & Mollin, D. L. (1966) Method of assay of red cell folate activity and the value of the assay as a test for folate deficiency. J. Clin. Pathol. 19: 17-28.
16. Kessler, D. A. (1993) Food standards: amendment of the standards of identity for enriched grain products to require addition of folic acid. Proposed rule. Fed. Regist. 58: 53305-53312.
17. Kessler, D. A. & Shalala, D. E. (1993) Food labeling: health claims and label statements; folate and neural tube defects. Proposed rule. Fed. Regist. 58: 53254-53294.
18. Kesslet, D. A. & Shalala, D. E. (1994) Food labeling: health claims and label statements; folate and neural tube defects. Notice. Fed. Regist. 59: 433-436.
19. Kirke, P. N., Molloy, A. M., Daly, L. E., Burke, H., Weir, D. G. & Scott, J. M. (1993) Maternal plasma folate and vitamin B-12 are independent risk factors for neural tube defects. Q. J. Med. 86: 703-708.
20. Laurence, K. M., James, N., Miller, M. H., Tennant, G. B. & Campbell, H. (1981) Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br. Med. J. 282: 1509-1511.
21. Little, J. (1992) Risk in siblings and other relatives. In: Epidemiology and Control of Neural Tube Defects (Elwood, M., Little, J. & Elwood, H., eds.), pp. 604-676. Oxford University Press, New York, NY.
22. Magnus, P., Magnus, E. M. & Berg, K. (1986) Increased levels of apotranscobalamins I and II in amniotic fluid from pregnant women with previous neural tube defect offspring. Clin. Genet. 30: 167-172.
23. Miller, S. A. & Stephenson, M. G. (1987) Food fortification: the need for scientific contribution. Bibl. Nutr. Dieta 40: 82-95.
24. Mills, J. L., McPartlin, J. M., Kirke, P. N., Lee, Y. J., Conley, M. R., Weir, D. G. & Scott, J. M. (1995) Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345: 149-151.
25. Mills, J. L., Tuomilehto, J., Yu, K. F., Colman, N., Blaner, W. S., Koskela, P., Rundle, W. E., Forman, M., Toivanen, L. & Rhoads, G. G. (1992) Maternal vitamin levels during pregnancies producing infants with neural tube defects. J. Pediatr. 120: 863-871.
26. Molloy, A. M., Kirke, P., Hillary, I., Weir, D. G. & Scott, J. M. (1985) Maternal serum folate and vitamin B-12 concentrations in pregnancies associated with neural tube defects. Arch. Dis. Child. 60: 660-665.
27. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 338: 131-137.
28. Mudd, S. H., Finkelstein, J. D., Irreverre, F. & Laster, L. (1964) Homocystinuria: an enzymatic defect. Science 143: 1443-1445.
29. Mudd, S. H., Levy, H. L. & Skovby, J. (1989) Disorders of transulfuration. In: The Metabolic Basis of Inherited Disease, 6th ed. McGraw-Hill, New York, NY.
30. Naurath, H. J., Joosten, E., Riezler, R., Stabler, S. O., Allen, R. H. & Lindenbaum, J. (1995) Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 346: 85-89.
31. Nosel, P. G. & Klein, N. W. (1992) Methionine decreases the embryotoxicity of sodium valproate in the rat: in vivo and in vitro observations. Teratology 46: 499-507.
32. NRC (National Research Council) (1989) Recommended Dietary Allowances, 10th ed. National Academy Press, Washington, DC.
33. Put, N. V. D., Steegers-Theunissen, R., Eskes, T., Trijbels, F., Heuvel, L. V. D., Mariman, E., Heyer, M. D., Rozen, R. & Blom, H. (1995) A common mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene as a risk factor for neural tube defects. Irish J. Med. Sci. 164(suppl. 15): 21 (abs.).
34. Romano, P. S., Waitzman, N. J., Scheffler, R. M. & Pi, R. D. (1995) Folic acid fortification of grain: an economic analysis. Am. J. Public Health 85: 667-676.
35. Rosenberg, I. H. (1992) Folic acid and neural-tube defects - time for action? N. Engl. J. Med. 327: 1875-1877.
36. Schorah, C. J., Wild, J., Hartley, R., Sheppard, S. & Smithells, R. W. (1983) The effect of penconceptional supplementation on blood vitamin concentrations in women at recurrence risk for neural tube defect. Br. J. Nutr. 49: 203-211.
37. Scott, J. M., Weir, D. G., Molloy, A., McPartlin, J., Daly, L. & Kirke, P. (1994) Folic acid metabolism and mechanisms of neural tube defects. In: Neural Tube Defects, Ciba Foundation Symposium 181, pp. 180-191. Wiley, Chichester, UK.
38. Scott, J. M., Kirke, P., O'Broin, S. & Weir, D. G. (1991) Folic acid to prevent neural tube defects. Lancet 338: 505 (lett.).
39. Shaw, G. M., Schaffer, D., Velie, E. M., Morland, K. & Harris, J. A. (1995) Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6: 219-226.
40. Silverman, A. (1980) Retrolental Fibroplasia: A Modem Parable. Grune & Stratton, New York, NY.
41. Smithells, R. W., Sheppard, S. & Schorah, C. J. (1976) Vitamin deficiencies and neural tube defects. Arch. Dis. Child. 51: 944-950.
42. Steegers-Theunissen, R. P. M., Boers, G. H. J., Trijbels, F. J. M. & Eskes, T. K. A. B. (1991) Neural-tube defects and derangement of homocysteine metabolism. N. Engl. J. Med. 324: 199-200.
43. Subar, A. F. & Bowering, J. (1988) The contribution of enrichment and fortification to nutrient intake of women. J. Am. Diet. Assoc. 88: 1237-1245.
44. Ubbink, J. B. (1994) Vitamin nutrition status and homocysteine: an atherogenic risk factor. Nutr. Rev. 52: 383-393.
45. Wild, J., Schorah, C. J., Sheldon, T. A. & Smithells, R. W. (1993) Investigation of factors influencing folate status in women who have had a neural tube defect-affected infant. Br. J. Obstet. Gynaecol. 100: 546-549.
46. Willett, W. C. (1992) Folic acid and neural tube defect: can't we come to closure? Am. J. Public Health 82: 666-668.
47. Yates, J. R. W., Ferguson-Smith, M. A., Shenkin, A., Guzman-Rodriguez, R., White, M. & Clark, B. J. (1987) Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects? Clin. Genet. 31: 279-287.